Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Correction: Liver injury and rosiglitazone.

    [No authors listed]

    Ann Intern Med. 2000 Aug 1;133(3):237. No abstract available. PMID: 10906846 [PubMed - indexed for MEDLINE]Related articles

    2.

    Rosiglitazone-induced granulomatous hepatitis.

    Dhawan M, Agrawal R, Ravi J, Gulati S, Silverman J, Nathan G, Raab S, Brodmerkel G Jr.

    J Clin Gastroenterol. 2002 May-Jun;34(5):582-4.PMID: 11960075 [PubMed - indexed for MEDLINE]Related articles

    3.

    Rosiglitazone toxicity.

    Ravinuthala RS, Nori U.

    Ann Intern Med. 2000 Oct 17;133(8):658. No abstract available. PMID: 11033603 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Liver failure in a patient treated with long-term rosiglitazone therapy.

    Gouda HE, Khan A, Schwartz J, Cohen RI.

    Am J Med. 2001 Nov;111(7):584-5. No abstract available. PMID: 11705443 [PubMed - indexed for MEDLINE]Related articles

    5.

    Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.

    McMorran M, Vu D.

    CMAJ. 2001 Jul 10;165(1):82-3, 86-7. English, French. No abstract available. PMID: 11468963 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Hepatotoxicity of the thiazolidinediones.

    Tolman KG, Chandramouli J.

    Clin Liver Dis. 2003 May;7(2):369-79, vi. Review.PMID: 12879989 [PubMed - indexed for MEDLINE]Related articles

    7.

    Isolated elevation of alkaline phosphatase level associated with rosiglitazone.

    Hachey DM, O'Neil MP, Force RW.

    Ann Intern Med. 2000 Nov 7;133(9):752. No abstract available. PMID: 11074926 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hepatocellular injury in a patient receiving rosiglitazone. A case report.

    Al-Salman J, Arjomand H, Kemp DG, Mittal M.

    Ann Intern Med. 2000 Jan 18;132(2):121-4. Erratum in: Ann Intern Med 2000 Aug 1;133(3):237. PMID: 10644273 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.

    Bonkovsky HL, Azar R, Bird S, Szabo G, Banner B.

    Dig Dis Sci. 2002 Jul;47(7):1632-7.PMID: 12141828 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rapid-onset subfulminant liver failure associated with troglitazone.

    Jagannath S, Rai R.

    Ann Intern Med. 2000 Apr 18;132(8):677. No abstract available. PMID: 10766693 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Troglitazone-associated hepatic failure.

    Misbin RI.

    Ann Intern Med. 1999 Feb 16;130(4 Pt 1):330. No abstract available. PMID: 10068399 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Meta-analysis shows: insulin sensitizer is safe for the liver]

    [No authors listed]

    MMW Fortschr Med. 2002 Oct 3;144(40):47. German. No abstract available. PMID: 12440297 [PubMed - indexed for MEDLINE]Related articles

    13.

    Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone.

    [No authors listed]

    Ann Intern Med. 2002 Mar 19;136(6):I65. No abstract available. Erratum in: Ann Intern Med 2002 May 7;136(9):711. PMID: 11900516 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    "Did this drug cause my patient's hepatitis?" and related questions.

    Nierenberg DW.

    Ann Intern Med. 2002 Mar 19;136(6):480-3. No abstract available. PMID: 11900502 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Substituting for troglitazone (Rezulin).

    [No authors listed]

    Med Lett Drugs Ther. 2000 Apr 17;42(1076):36. No abstract available. PMID: 10803176 [PubMed - indexed for MEDLINE]Related articles

    16.

    Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.

    Lenhard MJ, Funk WB.

    Diabetes Care. 2001 Jan;24(1):168-9. No abstract available. PMID: 11194222 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    From the Food and Drug Administration.

    Nightingale SL.

    JAMA. 1997 Dec 3;278(21):1728. No abstract available. PMID: 9388135 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.

    May LD, Lefkowitch JH, Kram MT, Rubin DE.

    Ann Intern Med. 2002 Mar 19;136(6):449-52.PMID: 11900497 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.

    Chan KA, Truman A, Gurwitz JH, Hurley JS, Martinson B, Platt R, Everhart JE, Moseley RH, Terrault N, Ackerson L, Selby JV.

    Arch Intern Med. 2003 Mar 24;163(6):728-34.PMID: 12639207 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings.

    Li H, Heller DS, Leevy CB, Zierer KG, Klein KM.

    J Diabetes Complications. 2000 May-Jun;14(3):175-7.PMID: 10989325 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data